eye - Blog - Global Risk Community2024-03-29T07:34:39Zhttps://globalriskcommunity.com/profiles/blogs/feed/tag/eyeBionic Eye is a Panacea of Lost Eyesighthttps://globalriskcommunity.com/profiles/blogs/bionic-eye-is-a-panacea-of-lost-eyesight2020-10-17T07:28:52.000Z2020-10-17T07:28:52.000ZKBV Researchhttps://globalriskcommunity.com/members/KBVResearch<div><p>Here’s why Bionic Eye is trending in the health-care sector. As per the report of the WHO, more than 40 million people are suffering from vision-related problems globally, and the majority of them are completely blind. Researchers and medical scientists are working diligently to develop new devices and techniques that can restore vision. With the application of some advanced technology, scientists have successfully developed a bionic eye that is effective in restoring visual disabilities. In developing countries around 80 % of people are suffering from problems related to eyesight, at the same time awareness is increasing among people regarding the treatment of ophthalmic diseases. This is resulting in the demand for the bionic eye.</p><p></p><p><a href="{{#staticFileLink}}8219693272,original{{/staticFileLink}}" target="_blank"><img src="{{#staticFileLink}}8219693272,original{{/staticFileLink}}" class="align-center" alt="8219693272?profile=original" /></a></p><h2><strong>What is a bionic eye?</strong></h2><p>The bionic eye is an artificial vision device. It is also called visual prosthetic. Bionic Eye has been designed as a wearable external system. It is a type of biomedical implants in which artificial devices are added to the body. A <a href="https://www.kbvresearch.com/bionic-eye-market/">bionic eye</a> is used to restore the visual disabilities of the patient who has either completely or partially lost the vision of the eye.</p><h2><strong>A Bionic eye consists of</strong></h2><p>The bionic eye consists of a camera attached to tiny eyeglasses, electrodes, and a transmitter that sends signals to an array of the electrode. This electrode is implanted onto the retina of the blind person. External hardware is connected in the bionic eye that capture images, process them, and create instructions.</p><p>It is based on a wireless telemetry system in which the transmitter transmits the signal to the electrode wirelessly. These signals are then conveyed to the implanted circuit via a telemetry link. Bionic Eye has been developed as a wearable external system that captures and processes the image, this system is supplemented by the implanted circuitry.</p><h2><strong>Are prosthetic and bionic eyes the same?</strong></h2><p>The bionic eye is very different from the prosthetic eye. A prosthetic eye is called a glass eye. They are implanted to replace the main physical structure of the eye. On the other hand, bionic eye implants work in the existing eye structure. This means the bionic eye doesn’t require the removal of the organ. A bionic eye is designed in such a way to restore the normal visual function of the eye in case of partial or complete blindness. This device captures and processes the image, and sends it to implanted circuitry.</p><h2><strong>Other treatments for the treatment of ophthalmic disease</strong></h2><p>In normal functioning of the eye, the light first enters the eye. The cornea and the lens focus this light to the retina with the help of other accessory parts of the eye. The rods and cones, which are light-sensitive cells convert light energy into electrical energy. These electrical signals are then sent to the brain through optic nerves.</p><p>There could be several reasons for partial or complete blindness, similarly, there are multiple options available for curing them. But before opting for any treatment, the main cause of visual impairment must be known. Those patients who have damaged cornea or lens are unable to focus the light on the retina, corneal transplantation or cataract surgery is done to restore vision and these are also cost-effective.</p><h2><strong>Future prospects of the bionic eye</strong></h2><p>The manufacturing companies are trying to add advancement to the device in which the number of electrodes will be increased that will capable of producing sharp images of the objects. Researchers are also testing a new device that can directly stimulate the brain and bypass the retina. Several models of the bionic eye have been proposed that target different areas of the visual pathways. But until now, the model involving retinal implants is only approved.</p><h2><strong>Limitations on the use of bionic eye</strong></h2><ul><li>It doesn’t impart 100% visibility to the blind people.</li><li>As the number of electrodes is less, it only facilitates reading large font books.</li><li>It is not helpful for glaucoma patients suffering from blindness.</li><li>The bionic eye is not able to perceive colors.</li><li>It is highly expensive.</li><li>The cost of such research processes is high, advance research requires more funds that became a major limitation in the adoption of the bionic eye.</li></ul><h2><strong>The bigger picture</strong></h2><p>The Bionic Eye Market has been showing rapid growth due to the increasing incidence of vision loss. As per the WHO report of 2019, more than 2.2 billion people are already suffering from blindness or vision-related impairment. The rise in the geriatric population, an increase in the number of patients suffering from chronic diseases, and the government’s attention to funding R&D initiatives are the main factors that are boosting the demand of bionic eye in the market. The increasing incidence of diseases related to the eyesight is directly related to the increasing prevalence of diseases like diabetes, heart attacks, etc., that why there is a huge need for bionic eye adoption.</p></div>Uveitis Treatment For Prevailing Uveitis Diseaseshttps://globalriskcommunity.com/profiles/blogs/uveitis-treatment-for-prevailing-uveitis-diseases2020-05-15T10:33:36.000Z2020-05-15T10:33:36.000ZKBV Researchhttps://globalriskcommunity.com/members/KBVResearch<div><p>Uveitis treatment advancements have revolutionized the diagnosis of multiple<span> </span><span style="color:#3366ff;"><a href="https://www.kbvresearch.com/uveitis-treatment-market/" style="color:#3366ff;">uveitis conditions</a></span><span> </span>such as anterior uveitis, posterior uveitis, moderate uveitis, and panuveitis. Many cases of uveitis are chronic and may lead to various potential problems, including corneal clouding, cataracts, elevated eye pressure (IOP), glaucoma, retinal inflammation, or retinal detachment.</p><p></p><p><a href="{{#staticFileLink}}8028317054,original{{/staticFileLink}}" target="_blank"><img src="{{#staticFileLink}}8028317054,original{{/staticFileLink}}" class="align-center" alt="8028317054?profile=original" /></a></p><p></p><p>These problems may result in a permanent loss of vision. The prevalence rates for uveitis vary in various parts of the world. Nevertheless, experts who reviewed 522 foreign papers on the causes and trends of uveitis and 22 global epidemiological studies found that 52.4 per 100,000 people were affected.</p><p></p><h2><strong>What is uveitis treatment and how does it work?</strong></h2><p>Uveitis is the inflammation of the middle tissue layer in the uvea eyewall which consists of the iris, choroid, and ciliary body. Various drug formulations such as anti-inflammatory drugs, cycloplegic agents, antimicrobial drugs, immunotherapy & targeted therapies, and others are used for uveitis treatment. These involve anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis. Inflammation of the iris called iritis or anterior uveitis is the most prevalent form of uveitis.</p><p></p><p>Increased prevalence of uveitis and growing awareness among the patient population with increased acceptance of innovative treatments are expected to drive the growth of the market. In addition, convenient access to uveitis treatment, increased demand for uveitis medications, and a boom in R&D activities to improve ideal uveitis treatment to further drive the growth of the industry.</p><p></p><h2><strong>Why is a uveitis treatment important?</strong></h2><p>The growing incidence of anterior uveitis is driving growth in large part. This disease causes the uvea of the eye to become inflamed in the anterior part. Treatment for these sight-threatening illnesses requires mainly corticosteroids and immunosuppressive agents. Corticosteroid eye drops are used in the majority of cases. Anterior uveitis can also grow as a consequence of various other diseases, which raises its prevalence.</p><p></p><p>Recent advancements in product applications and treatment modalities are ongoing, for example, a significant milestone was Humira’s approval for uveitis treatment. As a consequence, some of the driving factors are projected to be factors such as increasing geriatric population, increased incidence of the disease, and new product growth. Redness of the eyes, blurring of the vision, the small size of the pupil, and sensitivity to light may be symptoms of anterior uveitis which may result in permanent blindness if not treated.</p><p></p><h2><strong>Different types of uveitis details</strong></h2><h3><strong>Intermediate Uveitis</strong></h3><p>Intermediate uveitis (IU) is defined as inflammation of the anterior vitreous, ciliary, and peripheral retina. In the Standardization of Uveitis Nomenclature (SUN) International Workshop on Documentation of Clinical Results, the consensus reached was that the word IU will be used for that type of uveitis where vitreous is the main site of inflammation and where there is a related disorder (e.g. Lyme disease) or systemic disease (e.g. sarcoidosis).</p><p></p><h3><strong>Posterior Uveitis</strong></h3><p>Posterior uveitis is usually painless, but not always. Symptoms usually involve "floaters," little specks, flakes, or clouds that pass through the field of view, and reduced vision. Although anterior uveitis frequently causes eye and redness, light sensitivity, and blurred vision, the symptoms of posterior uveitis are more noticeable. Uveitis can lead to other complications, including glaucoma, cataracts, or retinal detachment. Effective diagnosis and care are critical to reducing the risk of irreversible vision loss.</p><p></p><p>Posterior uveitis arises as an acute illness or as part of certain conditions affecting the body (systemic) processes. The disease involves both males and females in similar proportions. This can happen at nearly any age, but it tends to occur more frequently between the ages of 20 and 50. According to one survey, 175,000 individuals in the United States and 800,000 people globally are affected by chronic, non-infectious posterior uveitis. About 80% of cases of uveitis affect the front (anterior) part of the eye.</p><p></p><h3><strong>Anterior Uveitis</strong></h3><p>Anterior uveitis is an intraocular swelling of the uveal tissues that is anterior to the center of the vitreous cavity. Along with conjunctivitis, keratitis, and acute glaucoma, it is part of a group of ocular disorders generally referred to as red-eye. It is associated with ocular damage as well as other infectious diseases, including juvenile rheumatoid arthritis, ankylosing spondylitis, reiter's syndrome, sarcoidosis, herpes zoster, and syphilis.</p><p></p><p>Common vision-threatening symptoms of anterior uveitis include cataracts, glaucoma, and macular oedema. Since anterior uveitis may be linked with the systemic disease which, when undetected which untreated, can cause vision loss, the value of ready access to primary eye care is a public health issue. The clinical treatment of anterior uveitis can be done by a detailed eye examination and a physical examination. Once correctly diagnosed, anterior uveitis can be treated and several complications can be prevented. Recognition of signs and symptoms of chronic causes of anterior uveitis and referral to treatment results in better patient health.</p><p></p><h2><strong>Barriers to New Drug Development</strong></h2><p>Since uveitis is unusual from a clinical trial point of view, a study involving several types of uveitis will encourage enrolment. However, the heterogeneity of uveitis poses 2 major barriers to successful drug development. First, effective treatment with one form of uveitis does not automatically cure all cases of uveitis. For example, multiple sclerosis is aggravated by TNF-a inhibition. Since pars planitis is associated with multiple sclerosis, anti-TNF therapy should be used with caution in these cases, particularly where there is a concern for demyelinating disease with a potential chance of developing de novo demyelinating disease.</p><p></p><h2><strong>The present scenario of uveitis treatment and future potential</strong></h2><p>The incidence of uveitis is growing as a primary driving factor leading to the growth of the demand for uveitis treatment. According to a 2015 report by the American University of Beirut Medical Center, Uveitis is responsible for 10 percent of U.S. legal blindness and up to 25 percent of developing countries’ blindness. In addition, according to a report conducted by F.I. Proctor Foundation, University of California, San Francisco, the incidence rate of uveitis among the U.S. population could be approximately 24.9 cases per 100,000.</p><p></p><p><strong>Free Valuable Insights:</strong><span> </span><span style="color:#3366ff;"><a href="https://www.kbvresearch.com/news/uveitis-treatment-market/" style="color:#3366ff;">Global Uveitis Treatment Market to reach a market size of USD 686.1 million by 2025</a></span></p><p></p><p>Furthermore, some other factors driving market growth include a rise in healthcare spending for the production of treatment and the development of new and innovative uveitis medication biologics. Nevertheless, factors restricting market development include side effects related to immunosuppressant medications such as kidney damage, high blood sugar, and osteoporosis. Also, medication-related complications may result in permanent blindness, which is a significant limiting factor to market growth.</p></div>Biometric Authentication and Identification Market Share and Industry Report, 2018-2023https://globalriskcommunity.com/profiles/blogs/biometric-authentication-and-identification-market-share-and2019-05-01T12:00:00.000Z2019-05-01T12:00:00.000ZBIS Researchhttps://globalriskcommunity.com/members/BISResearch<div><p><a href="{{#staticFileLink}}8028288288,original{{/staticFileLink}}" target="_blank"><img src="{{#staticFileLink}}8028288288,original{{/staticFileLink}}" class="align-center" alt="8028288288?profile=original" /></a></p><p>The global facial recognition market value is estimated to be $XX billion in 2018. The government application segment is accommodating a major share of the biometric market and is expected to grow over $XX billion by 2023 from an estimated value of $XX billion in 2018, because of an increase in the deployment of biometrics products in border security, and also due to the growth of video surveillance. The second major application segment of facial biometrics is in banking and financial institutions. This is attributed to the rising security concerns since the last few years, leading to an increasing deployment of facial recognition biometrics products in the banking and financial institutions. The facial recognition in the banking and financial institutions is expected to grow over $XX billion by 2023 at a CAGR of XX% from 2018 to 2023. However, the enterprise segment is anticipated to be growing at the highest CAGR of XX% during the forecast period.</p><p><strong>Request the Sample @ <a href="https://bisresearch.com/requestsample?id=673&type=download">https://bisresearch.com/requestsample?id=673&type=download</a></strong></p><p>Asia-Pacific is projected to lead the market by 2023 at a CAGR of XX% from 2018 to 2023, and is expected to account for a value of $XX billion in 2023. The primary reason for its dominance is the ID enrolment projects that have been started in countries such as China and India. Moreover, Africa and Middle East in the Rest-of-the-World region constitute a very small market for facial recognition, but is expected to grow at the highest CAGR of XX%, during the forecast period.</p><p><strong>View Complete Report @ <a href="https://bisresearch.com/industry-report/biometric-authentication-identification-market.html" target="_blank">Biometric Authentication and Identification Report</a></strong></p><p>The commercially available facial recognition systems are two dimensional (2D), three dimensional (3D), or a combination of both 2D and 3D features. The 2D facial recognition systems are gradually becoming obsolete since the 3D systems ensure a higher level of accuracy and reliability than their 2D systems. The biometric system market players have identified this opportunity and are competing in the market with innovative and versatile product portfolios. Moreover, 3D facial recognition systems have overcome the pitfalls of 2D face recognition algorithms as change in lighting, different facial expressions, make-up, and head orientation. The prospecting technologies are skin texture analysis, thermal imaging, emotion capturing, and many others.</p><p><strong>Related Reports:</strong></p><p><strong><a href="https://bisresearch.com/industry-report/video-surveillance-market.html" target="_blank">Global Video Surveillance Market - Analysis and Forecast: 2018-2023</a></strong></p><p><strong><a href="https://bisresearch.com/industry-report/global-fingerprint-sensors-market-2023.html" target="_blank">Global Fingerprint Sensors Market, Analysis and Forecast, 2017-2023</a></strong></p><p><strong><a href="https://bisresearch.com/industry-report/global-forensic-product-services-market-forecast.html" target="_blank">Global Forensic Technology Market, Analysis & Forecast: 2016 to 2022</a></strong></p><p><strong>About Us:</strong></p><p>BIS Research is a global market intelligence, research and advisory company which focuses on those emerging trends in technology which are likely to disrupt the dynamics of the market over the next five (or ten) years.</p><p>With over 150 market intelligence reports published annually, BIS Research focuses on various technology verticals such as 3D printing, advanced materials & chemicals, aerospace and defense, automotive, healthcare, electronics & semiconductors, robotics & UAV and other emerging technologies.</p><p>Each research report incorporates detailed analysis and subsequent quantification of- market dynamics, market drivers and restraints, opportunities, threats, market shares, current and emerging industry trends as well as detailed competitive landscape and intelligence.</p><p><strong>Contact:</strong></p><p><strong>39111 PASEO PADRE PKWY STE 313,</strong><br /> <strong>FREMONT CA 94538-1686,</strong> <br /> <strong>E-mail : sales@bisresearch.com</strong><br /> <strong>Call Us : +1-510-404-8135</strong></p></div>